This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Applied Cognition, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Innovations of Carl J Weber
Introduction
Carl J Weber is an accomplished inventor based in Portola Valley, California. He has made significant contributions to the field of neurophysiology and neurovascular research. With a total of two patents to his name, Weber is recognized for his innovative approaches to assessing neurodegeneration.
Latest Patents
Weber's latest patents focus on non-invasive methods for assessing glymphatic flow and neurodegeneration through wearable devices. The first patent describes a computer-implemented method and system that accesses neurophysiological and neurovascular data recorded during sleep. A function mapping is executed from this data to identify targets such as glymphatic flow markers, molecular analysis markers of neurodegeneration, or neuroimaging markers of neurodegeneration. The output is a target prediction model that can utilize new data to predict markers of neurodegeneration.
Career Highlights
Throughout his career, Carl J Weber has demonstrated a commitment to advancing medical technology. His work has the potential to revolutionize how neurodegenerative conditions are monitored and diagnosed. By integrating wearable technology with neurophysiological data, Weber is paving the way for more accessible and effective health assessments.
Collaborations
Weber collaborates with notable professionals in his field, including Paul Dagum and Gregory T A Kovacs. These partnerships enhance the research and development of innovative solutions in neurophysiology.
Conclusion
Carl J Weber's contributions to the field of neurophysiology through his patents and collaborations highlight his role as a leading inventor. His work not only advances scientific understanding but also has the potential to improve patient care in neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile